High-risk diabetic patients in medicare part d programs: Are they getting the recommended ACEI/ARB therapy?

Journal of General Internal Medicine

Volumn 25, Issue 4, 2010, Pages 298-304

  Yang, Yi ^a   Thumula, Vennela ^a   Pace, Patrick F ^a   Banahan III, Benjamin F ^a   Wilkin, Noel E ^a   Lobb, William B ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

ACEI ARB; Diabetes; Hypertension; Medicare Part D; Renal disease

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG USE; EVIDENCE BASED MEDICINE; FEMALE; HEALTH PROGRAM; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INTERVENTION STUDY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICARE; OUTCOME ASSESSMENT; PRESCRIPTION; RETROSPECTIVE STUDY; TREATMENT RESPONSE; UNITED STATES;

AGED; ANALYSIS OF VARIANCE; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; COHORT STUDIES; CONFIDENCE INTERVALS; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERTENSION; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MEDICARE PART D; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; UNITED STATES;

EID: 77951132907     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-009-1242-z     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention 2008 State-specific incidence of diabetes among adults-participating states, 1995-1997 and 2005-2007 MMWR Morb Mortal Wkly Rep 57 43 1169 1173
2. Centers for Disease Control and Prevention. National diabetes fact sheet. Available at: http://www.cdc.gov/diabetes/pubs/factsheet07.htm. Accessed October 28, 2009.
3. AI Adler IM Stratton HA Neil JS Yudkin DR Matthews CA Cull, et al. 2000 Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study BMJ 321 7258 412 419 10.1136/bmj.321.7258.412 1:STN:280:DC%2BD3cvisFWnsw%3D%3D 10938049
4. S Lewington R Clarke N Qizilbash R Peto R Collins 2002 Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for 1 million adults in 61 prospective studies Lancet 360 9349 1903 1913 10.1016/S0140-6736(02)11911-8 12493255 (Pubitemid 35472129)
5. J Stamler O Vaccaro JD Neaton D Wentworth 1993 Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 16 2 434 444 10.2337/diacare.16.2. 434 1:STN:280:DyaK3s7mtFyrtQ%3D%3D 8432214
6. RR Holman SK Paul MA Bethel HA Neil DR Matthews 2008 Long-term follow-up after tight control of blood pressure in type 2 diabetes N Engl J Med 359 15 1565 1576 10.1056/NEJMoa0806359 1:CAS:528:DC%2BD1cXht1Wgt7zM 18784091
7. American diabetes association 2009 Standards of medical care in diabetes-2009 Diabetes Care 32 Suppl 1 S13 S61 10.2337/dc09-S013
8. National Kidney Foundation. K/DOQI clinical guidelines for chronic kidney disease: evaluation, classification, and stratification. Available at: http://www.kidney.org/professionals/kdoqi/guidelines-ckd/toc.htm. Accessed October 28, 2009.
9. HW Rodbard L Blonde SS Braithwaite EM Brett RH Cobin Y Handelsman, et al. 2007 American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus Endocr Pract 13 Suppl 1 1 68 17613449
10. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet. 2000;355(9200):253-9.
11. BM Brenner ME Cooper D de Zeeuw WF Keane WE Mitch HH Parving, et al. 2001 Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 12 861 869 10.1056/NEJMoa011161 1:CAS:528:DC%2BD3MXntlelsLk%3D 11565518
12. EJ Lewis LG Hunsicker RP Bain RD Rohde 1993 The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group N Engl J Med 329 20 1456 1462 10.1056/ NEJM199311113292004 1:STN:280:DyaK2c%2FhvFKitQ%3D%3D 8413456 (Pubitemid 23335891)
13. EJ Lewis LG Hunsicker WR Clarke T Berl MA Pohl JB Lewis, et al. 2001 Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 345 12 851 860 10.1056/NEJMoa011303 1:CAS:528:DC%2BD3MXntlelsLg%3D 11565517
14. HH Parving H Lehnert J Brochner-Mortensen R Gomis S Andersen P Arner 2001 The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes N Engl J Med 345 12 870 878 10.1056/NEJMoa011489 1:CAS:528:DC%2BD3MXntlelsLY%3D 11565519
15. G Remuzzi M Macia P Ruggenenti 2006 Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study J Am Soc Nephrol 17 4 Suppl 2 S90 S97 10.1681/ASN.2005121324 16565256
16. CE Cooke H Fatodu 2006 Physician conformity and patient adherence to ACE inhibitors and ARBs in patients with diabetes, with and without renal disease and hypertension, in a medicaid managed care organization J Manag Care Pharm 12 8 649 655 17269843
17. AB Rosen AJ Karter JY Liu JV Selby EC Schneider 2004 Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes J Gen Intern Med 19 6 669 675 10.1111/j.1525-1497.2004.30264.x 15209606 (Pubitemid 38803158)
18. AB Rosen 2006 Indications for and utilization of ACE inhibitors in older individuals with diabetes. Findings from the National Health and Nutrition Examination Survey 1999 to 2002 J Gen Intern Med 21 4 315 319 10.1111/j.1525-1497.2006.00351.x 16686805
19. C Arauz-Pacheco MA Parrott P Raskin 2004 Hypertension management in adults with diabetes Diabetes Care 27 Suppl 1 S65 S67 14693929
20. ME Molitch RA DeFronzo MJ Franz WF Keane CE Mogensen HH Parving, et al. 2004 Nephropathy in diabetes Diabetes Care 27 Suppl 1 S79 S83 14693934
21. IB Ahluwalia KA Mack W Murphy AH Mokdad VS Bales 2003 State-specific prevalence of selected chronic disease-related characteristics-Behavioral Risk Factor Surveillance System, 2001 MMWR Surveill Summ 52 8 1 80 14532868
22. PM Ho JS Rumsfeld FA Masoudi DL McClure ME Plomondon JF Steiner, et al. 2006 Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus Arch Intern Med 166 17 1836 1841 10.1001/archinte.166.17.1836 17000939 (Pubitemid 44455165)
23. WC Winkelmayer MA Fischer S Schneeweiss PS Wang R Levin J Avorn 2005 Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes Am J Kidney Dis 46 6 1080 1087 10.1053/j.ajkd.2005.08.018 1:CAS:528:DC%2BD2MXhtlGitLjJ 16310574 (Pubitemid 41690234)
24. S Boyer V Kapur 2002 Obstructive sleep apnea: its relevance in the care of diabetic patients Clin Diabetes 20 3 126 132 10.2337/diaclin.20.3.126
25. RP Hertz AN Unger MB Lustik 2005 Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance Clin Ther 27 7 1064 1073 10.1016/j.clinthera.2005.07.009 16154485 (Pubitemid 41262464)
26. JN Struijs CA Baan FG Schellevis GP Westert GA van den Bos 2006 Comorbidity in patients with diabetes mellitus: impact on medical health care utilization BMC Health Serv Res 6 84 10.1186/1472-6963-6-84 16820048 (Pubitemid 44214753)
27. JF Steiner AV Prochazka 1997 The assessment of refill compliance using pharmacy records: methods, validity, and applications J Clin Epidemiol 50 1 105 116 10.1016/S0895-4356(96)00268-5 1:STN:280:DyaK2s3gtVyltA%3D%3D 9048695 (Pubitemid 27089212)
28. DR Arday BB Fleming DK Keller PW Pendergrass RJ Vaughn JM Turpin, et al. 2002 Variation in diabetes care among states: do patient characteristics matter? Diabetes Care 25 12 2230 2237 10.2337/diacare.25.12.2230 12453966 (Pubitemid 41071033)
29. MW Massing N Henley D Biggs A Schenck RJ Simpson Jr 2003 Prevalence and care of diabetes mellitus in the Medicare population of North Carolina. Baseline findings from the Medicare Healthcare Quality Improvement Program N C Med J 64 2 51 57 12774733
30. JF Riehle DT Lackland EC Okonofua KH Hendrix BM Egan 2005 Ethnic differences in the treatment and control of hypertension in patients with diabetes J Clin Hypertens (Greenwich) 7 8 445 454 10.1111/j.1524-6175.2005. 04542.x
31. PC Deedwania 2005 Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy Cardiol Clin 23 2 139 152 10.1016/j.ccl.2004.06.006 15694743 (Pubitemid 40203090)